A 49-year-old COVID-19 patient after he was administered plasma therapy. Though there could be many other factors behind his recovery, this method is surely a ray of hope for many suffering from this deadly virus.
A new drug, lenalidomide, improves the overall survival rate of younger bone marrow cancer patients.
The study showed older mice given young blood did not develop age-related diseases and maintained sharp cognitive function, while younger ones given older blood saw the opposite effect.
In India, incidence of multiple myeloma affects 1.8 per cent in a population of 100,000. Approximately, 50,000 new cases of multiple myeloma are diagnosed each year.
Who is not eligible for plasma donation?
Bone survey
B lymphocytes
Myeloma
A 49-year-old COVID-19 patient after he was administered plasma therapy. Though there could be many other factors behind his recovery, this method is surely a ray of hope for many suffering from this deadly virus.
A new drug, lenalidomide, improves the overall survival rate of younger bone marrow cancer patients.
The study showed older mice given young blood did not develop age-related diseases and maintained sharp cognitive function, while younger ones given older blood saw the opposite effect.
In India, incidence of multiple myeloma affects 1.8 per cent in a population of 100,000. Approximately, 50,000 new cases of multiple myeloma are diagnosed each year.
Who is not eligible for plasma donation?
Bone survey
B lymphocytes
Myeloma
